T3	PROC 161 192	evaluar la eficacia y seguridad
T4	CHEM 196 207	tozorakimab
T6	LIVB 222 231	pacientes
#2	AnnotatorNotes T6	C0030705; Patients; Patient or Disabled Group
T7	PROC 232 246	hospitalizados
#3	AnnotatorNotes T7	C0019993; Hospitalization; Health Care Activity
T8	DISO 251 276	infección pulmonar vírica
T9	PROC 291 305	oxigenoterapia
#4	AnnotatorNotes T9	C0184633; Oxygen Therapy Care; Therapeutic or Preventive Procedure
T10	DISO 328 358	Infecciones pulmonares víricas
T11	LIVB 394 411	Pacientes adultos
T12	Age 404 411	adultos
T13	Age 412 421	≥ 18 años
T14	PROC 449 473	consentimiento informado
#5	AnnotatorNotes T14	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T15	LIVB 478 487	Pacientes
#6	AnnotatorNotes T15	C0030705; Patients; Patient or Disabled Group
T16	PROC 488 502	hospitalizados
#7	AnnotatorNotes T16	C0019993; Hospitalization; Health Care Activity
T17	DISO 507 532	infección pulmonar vírica
T18	DISO 537 546	Hipoxemia
#8	AnnotatorNotes T18	C0700292; Hypoxemia; Finding
T20	CHEM 590 597	oxígeno
#9	AnnotatorNotes T20	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T21	DISO 627 667	Infección pulmonar fúngica o parasitaria
T22	DISO 678 711	infección pulmonar por aspiración
T23	DISO 713 729	absceso pulmonar
#10	AnnotatorNotes T23	C0024110; Lung Abscess; Disease or Syndrome
T24	DISO 732 747	sepsis pulmonar
T25	DISO 763 785	coinfección bacteriana
T26	LIVB 813 825	investigador
#11	AnnotatorNotes T26	C0035173; Research Personnel; Professional or Occupational Group
T27	DISO 830 850	infección bacteriana
#12	AnnotatorNotes T27	C0004623; Bacterial Infections; Disease or Syndrome
T28	LIVB 885 893	paciente
#13	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	DISO 898 907	Hipoxemia
#14	AnnotatorNotes T29	C0700292; Hypoxemia; Finding
T30	DISO 935 955	lesión extrapulmonar
T31	DISO 962 977	lesión pulmonar
#15	AnnotatorNotes T31	C0577916; Lesion of lung; Finding | C2350019; Solitary Pulmonary Nodule; Neoplastic Process
T32	Neg_cue 991 993	no
T33	DISO 994 1004	infecciosa
#16	AnnotatorNotes T33	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T34	Negated 994 1004	infecciosa
T35	Date 1018 1026	en curso
T36	PROC 1045 1059	aleatorización
#17	AnnotatorNotes T36	C0034656; Randomization; Research Activity
T37	CHEM 209 217	MEDI3506
T5	PROC 560 571	tratamiento
T19	PROC 1013 1017	ECMO
T38	PROC 1009 1012	IMV
T1	PROC 47 154	Ensayo multicéntrico Fase III, aleatorizado, doble-ciego, de grupos paralelos y controlado frente a placebo
